Skip to contentSkip to Braille Studio

Library / Laws / 115th Congress / House Bills / H.R. 6294

H.R. 6294

To amend the Federal Food, Drug, and Cosmetic Act to encourage the development of priority antimicrobial products through the award of a transferable exclusivity extension period, and for other purposes.

Print stageDateSize⠃
Introduced in House2018-06-2815.6K⠃⠗⠋